SIRT3 Protein - Mitochondrial Sirtuin

SIRT3 Protein - Mitochondrial Sirtuin

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SIRT3 Protein - Mitochondrial Sirtuin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWU1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~44 kDa (full-length), ~28 kDa (processed mature form)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondria matrix</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Sirtuin family (Class I)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain, heart, liver, kidney; moderate in skeletal muscle</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>Honokiol</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT1720</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT2104</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NMN (Nicotinamide mononucleotide)</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NR (Nicotinamide riboside)</td>
</tr>
<tr>
<td class="label">Indirect activation</td>
<td>Resveratrol</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">

SIRT3 Protein - Mitochondrial Sirtuin

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">SIRT3 Protein - Mitochondrial Sirtuin</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>SIRT3</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9NWU1</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~44 kDa (full-length), ~28 kDa (processed mature form)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Mitochondria matrix</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Sirtuin family (Class I)</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in brain, heart, liver, kidney; moderate in skeletal muscle</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>Honokiol</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT1720</td>
</tr>
<tr>
<td class="label">Direct SIRT3 activators</td>
<td>SRT2104</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NMN (Nicotinamide mononucleotide)</td>
</tr>
<tr>
<td class="label">NAD⁺ boosters</td>
<td>NR (Nicotinamide riboside)</td>
</tr>
<tr>
<td class="label">Indirect activation</td>
<td>Resveratrol</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-seaad-v4-5a7a4079" style="color:#ce93d8" title="Score: 0.68">SIRT3-Mediated Mitochondrial Deacetylati...</a><br><a href="/hypothesis/h-0e614ae4" style="color:#ce93d8" title="Score: 0.45">Mitochondrial-Nuclear Epigenetic Cross-T...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">725 edges</a></td>
</tr>
</table>

Overview

SIRT3 (Sirtuin 3) is a NAD⁺-dependent deacetylase enzyme localized primarily to the mitochondrial matrix, where it serves as the primary mitochondrial protein deacetylase. SIRT3 plays critical roles in regulating cellular metabolism, oxidative stress responses, and mitochondrial quality control—all processes fundamental to neuronal survival in neurodegenerative diseases. This page provides comprehensive information about SIRT3's structure, function, and significance in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative conditions. [@lombard2020]

Introduction

Sirtuins (SIRT1-7) are a highly conserved family of NAD⁺-dependent deacetylases that regulate cellular homeostasis through protein deacetylation. SIRT3 is uniquely positioned as the major mitochondrial deacetylase, with broad substrate specificity targeting over 20% of mitochondrial proteins. In the brain, SIRT3 expression is highest in regions with high metabolic demand, including the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and substantia nigra—areas particularly vulnerable to neurodegeneration. [@hirschey2010]

Protein Overview

Structure

SIRT3 protein structure consists of several key domains:

Primary Structure

• N-terminal mitochondrial targeting sequence (MTS): First ~25 amino acids that direct import into mitochondria
• Catalytic core domain: Rossmann-fold structure (~275 amino acids)
• NAD⁺-binding pocket: Highly conserved sirtuin signature motif (VTN/VGAGV)
• Acetyl-lysine binding pocket: Substrate recognition region

Tertiary Structure

Post-Translational Processing

Normal Function

Enzymatic Activity

• Deacetylation: Primary activity; removes acetyl groups from lysine residues
• Demalonylation: Removes malonyl groups (recently discovered)
• Desuccinylation: Removes succinyl groups
• ADP-ribosylation: Lower activity (controversial)

Metabolic Regulation

• IDH2 (Isocitrate dehydrogenase 2): Enhances NADP⁺/NADPH production, supporting antioxidant defenses
• SDH (Succinate dehydrogenase): Optimizes Complex II activity in ETC
• GDH (Glutamate dehydrogenase): Regulates amino acid metabolism
• LCAD (Long-chain acyl-CoA dehydrogenase): Fatty acid β-oxidation
• HMGCS2 (Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2): Ketogenesis

Antioxidant Defense

• SOD2 (Superoxide dismutase 2): Deacetylates SOD2 at Lys-122, dramatically increasing its activity
• OGG1 (8-oxoguanine DNA glycosylase): Enhances DNA repair capacity
• IDH2: Increases NADPH production for glutathione reductase

Mitochondrial Quality Control

• Complex I: Deacetylates NDUFA9, optimizing NADH oxidation
• Complex III: Regulates cytochrome c oxidase activity
• TFAM: Influences mitochondrial DNA transcription

Additional Functions

• [Apoptosis](/entities/apoptosis) regulation: Deacetylates p53, modulating pro-apoptotic signaling
• Calcium homeostasis: Influences mitochondrial calcium buffering
• Lipid metabolism: Regulates fatty acid oxidation and ketogenesis

Role in Neurodegeneration

Alzheimer's Disease

SIRT3 provides multifaceted protection in AD:

[Amyloid-Beta](/proteins/amyloid-beta) Toxicity

• SIRT3 deacetylates SOD2, enhancing clearance of ROS generated by Aβ accumulation
• Protects against Aβ-induced mitochondrial dysfunction in hippocampal [neurons](/entities/neurons)
• SIRT3 activation reduces Aβ-induced apoptosis in neuronal cultures

• Maintains mitochondrial membrane potential and ATP production
• Preserves electron transport chain integrity in neurons
• Protects against Aβ-induced Complex I and III dysfunction

• Reduces [NLRP3](/entities/nlrp3-inflammasome) inflammasome activation via deacetylation
• Modulates microglial activation and cytokine production

• SIRT3 expression is significantly reduced in AD brain (temporal cortex, hippocampus)
• Lower SIRT3 levels correlate with cognitive decline severity
• SIRT3 polymorphisms associated with AD risk in some populations

• SIRT3 activators (honokiol, SRT1720) show promise in AD mouse models
• NAD⁺ boosters (NMN, NR) increase SIRT3 activity indirectly
• Overexpression of SIRT3 reduces Aβ pathology in [APP](/entities/app-protein)/PS1 mice

Parkinson's Disease

SIRT3 is particularly important for dopaminergic neuron survival:

Mitochondrial Protection

• Maintains Complex I activity, critical for dopaminergic neurons
• Protects against 6-OHDA and MPTP-induced toxicity
• Preserves mitochondrial membrane potential in substantia nigra neurons

• SOD2 deacetylation provides crucial ROS detoxification
• Protects against iron-induced oxidative damage (relevant to PD iron accumulation)
• Maintains glutathione levels in dopaminergic cells

• SIRT3 protects against α-synuclein-induced mitochondrial dysfunction
• Reduces α-synuclein aggregation in cellular models
• May influence prion-like propagation of α-synuclein

• SIRT3 activators protect dopaminergic neurons in MPTP models
• NAD⁺ supplementation increases SIRT3 activity
• Honokiol administration reduces dopaminergic loss in Parkin-deficient mice

Amyotrophic Lateral Sclerosis (ALS)

Motor Neuron Vulnerability

• Motor neurons have high metabolic demands and mitochondrial content
• SIRT3 protects against oxidative stress in motor neurons
• SIRT3 levels reduced in ALS models and patient tissue

• Maintains mitochondrial ATP production
• Protects against SOD1 mutation-induced mitochondrial damage
• Preserves axonal mitochondrial transport

• SIRT3 activation protects motor neurons in SOD1-G93A mice
• NAD⁺ boosters show benefit in ALS models
• SIRT3-5-Fluorouracil interaction under investigation

Other Neurodegenerative Conditions

Huntington's Disease

• Protects against mutant [huntingtin](/proteins/huntingtin-protein)-induced mitochondrial dysfunction
• SIRT3 activators improve motor performance in HD models
• Modulates BDNF signaling

• May protect against oligodendrocyte dysfunction
• Relevant to autonomic nervous system degeneration

• SIRT3 targets frataxin-deficient mitochondria
• Potential therapeutic target

Mechanism of Action

Signaling Pathways

Aβ / α-Syn / Mutant Proteins
↓
Mitochondrial Damage
↓
ROS Production ↑
↓
SIRT3 Activation (NAD⁺-dependent)
↓
SOD2 Deacetylation → Activation
↓
ROS Clearance ↑
↓
Mitochondrial Function Preservation
↓
Neuronal Survival ↑

Key Molecular Interactions

• NAD⁺ binding: Required for deacetylase activity; cellular NAD⁺ levels directly regulate SIRT3
• Acetyl-CoA: High mitochondrial acetyl-CoA can inhibit SIRT3 activity
• p53: Deacetylation modulates apoptosis pathway
• FOXO3a: Deacetylation enhances antioxidant gene expression
• PGC-1α: Indirect regulation of mitochondrial biogenesis

Therapeutic Targeting

Biomarkers

SIRT3 as a Biomarker

• Blood/CSF levels: Can be measured via ELISA
• Activity assays: Functional deacetylation measurements
• Clinical correlation: Levels correlate with disease severity in some studies

Diagnostic Potential

• Not yet validated for clinical diagnosis
• Research use in distinguishing disease subtypes
• Potential for monitoring treatment response

Research Challenges

Key Publications

Background

The study of Sirt3 Protein Mitochondrial Sirtuin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway & Interaction Diagram

Interactive diagram showing SIRT3 key relationships in the SciDEX knowledge graph (15 connections shown).

See Also

• SIRT3 Gene
• [SIRT1 Protein](/proteins/sirt1-protein)
• [SIRT2 Protein](/proteins/sirt2-protein)
• [Mitochondrial Dysfunction Pathway](/mechanisms/mitochondrial-dysfunction)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress)